Cover Image
市場調查報告書

心臟病發作:全球臨床實驗檢討

Heart Attack Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 312394
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
心臟病發作:全球臨床實驗檢討 Heart Attack Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月10日 內容資訊: 英文 78 Pages
簡介

本報告提供心臟病發作的疼痛相關臨床研究的最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,地區、階段、phase別進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 心臟病發作
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 心臟病發作 臨床實驗數量中心臟血管臨床實驗數量比率

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 心臟病發作 臨床實驗數量中心臟血管臨床實驗數量比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 心臟病發作 治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • 武田藥品工業
    • Sociedade Tecnico-Medicinal, S.A.
    • GlaxoSmithKline plc
    • Kowa American Corporation
    • IPCA Laboratories Limited
    • Bayer AG
    • AstraZeneca PLC
    • Amgen Inc.
  • 有代表性的研究機關醫院臨床實驗概要
    • University College Cork
    • Brigham and Women's Hospital
    • Sheffield Teaching Hospitals NHS Foundation Trust
  • Trust
    • Yale University
    • William Beaumont Hospitals
    • University of Southern Denmark
    • University of Edinburgh
    • University of Ottawa Heart Institute
    • University of Illinois
    • University of Auckland

5大臨床實驗簡介

圖表一覽

目錄

GlobalData's clinical trial report, "Heart Attack Global Clinical Trials Review, H2, 2014" provides data on the Heart Attack clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Attack. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Heart Attack. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Heart Attack
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Heart Attack to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Heart Attack to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Heart Attack
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Heart Attack Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Sociedade Tecnico-Medicinal, S.A.
      • Clinical Trial Overview of Sociedade Tecnico-Medicinal, S.A.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Kowa American Corporation
      • Clinical Trial Overview of Kowa American Corporation
      • IPCA Laboratories Limited
      • Clinical Trial Overview of IPCA Laboratories Limited
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University College Cork
      • Clinical Trial Overview of University College Cork
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Sheffield Teaching Hospitals NHS Foundation Trust
      • Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust
      • Yale University
      • Clinical Trial Overview of Yale University
      • William Beaumont Hospitals
      • Clinical Trial Overview of William Beaumont Hospitals
      • University of Southern Denmark
      • Clinical Trial Overview of University of Southern Denmark
      • University of Edinburgh
      • Clinical Trial Overview of University of Edinburgh
      • University of Ottawa Heart Institute
      • Clinical Trial Overview of University of Ottawa Heart Institute
      • University of Illinois
      • Clinical Trial Overview of University of Illinois
      • University of Auckland
      • Clinical Trial Overview of University of Auckland
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Heart Attack Therapeutics, Global, Clinical Trials by Region, 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Heart Attack Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Heart Attack Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Heart Attack Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Heart Attack Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Heart Attack Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Heart Attack to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Heart Attack Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Heart Attack Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Heart Attack to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Heart Attack Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Heart Attack Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Heart Attack Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Heart Attack Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Sociedade Tecnico-Medicinal, S.A., 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa American Corporation, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by IPCA Laboratories Limited, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University College Cork, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by William Beaumont Hospitals, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern Denmark, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Edinburgh, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2014*
  • Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Auckland, 2014*

List of Figures

  • Heart Attack Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Heart Attack Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Heart Attack Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Heart Attack Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Heart Attack Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Heart Attack Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Heart Attack to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Heart Attack Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Heart Attack Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Heart Attack to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Heart Attack Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Heart Attack Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Heart Attack Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Heart Attack Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Heart Attack Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top